When did CITIUS ONCOLOGY INC (CTOR) report earnings last quarter?
CITIUS ONCOLOGY INC (CTOR) last reported earnings on 2/13/2026.
CITIUS ONCOLOGY INC (CTOR) Earnings History & Surprises
NASDAQ:CTOR • US17331Y1091
Current stock price
0.6369 USD
-0.01 (-0.96%)
Last:
CTOR Earnings overview
Past quarterly earnings results for CITIUS ONCOLOGY INC (CTOR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 12, 2026
- Period
- Q2 / 2026
- EPS Estimate
- -$0.01
- Revenue Estimate
- 7.137M
Last Reported
Most Recent- Release Date
- Feb 13, 2026
- Period
- Q1 / 2026
- EPS Reported
- -$0.06
- EPS Surprise
- -198.04%
- Revenue Surprise
- -11.66%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | -0.06 | 0.06 | -198.04% | 33.33% | 3.94M | 4.46M | -11.66% | - |
| Q4 2025 | -0.06 | -0.12 | 50.98% | - | - | - | ||
| Q3 2025 | -0.08 | -0.15 | 47.71% | - | - | - | ||
| Q2 2025 | -0.11 | -0.09 | -19.83% | - | 5.851M | -100.00% | - | |
| Q1 2025 | -0.09 | -0.06 | -47.06% | - | - | - | ||
| Q4 2024 | - | - | - | - | ||||
| Q3 2024 | - | - | - | - | ||||
| Q2 2024 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-29.79%
Max EPS beat (4)
50.98%
Min EPS beat (4)
-198.04%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, CTOR has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, CTOR reported -29.8% below the EPS estimates on average.
Related analysis
CITIUS ONCOLOGY INC / CTOR Earnings FAQ
Did CITIUS ONCOLOGY INC (CTOR) beat earnings estimates last quarter?
CITIUS ONCOLOGY INC (CTOR) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does CITIUS ONCOLOGY INC (CTOR) beat earnings estimates?
In the last 4 quarters, CITIUS ONCOLOGY INC (CTOR) has beaten EPS estimates in 2 out of 4 releases.